Literature DB >> 3458975

Retinoic acid induced HL-60 myeloid differentiation: dependence of early and late events on isomeric structure.

A Yen, V Powers, J Fishbaugh.   

Abstract

The capability of HL-60 cells to undergo G1/0 specific growth arrest and myeloid differentiation in response to isomers of retinoic acid (RA) having an altered alkyl chain was determined. At a concentration where beta-all trans RA induces myeloid differentiation and G1/0 specific growth arrest, 11,13-dicis and 9,13-dicis isomers failed to induce significant phenotypic differentiation, assayed by the inducible superoxide production characteristic of mature myeloid cells, but could induce moderate G1/0 specific growth arrest. The 9-cis and 11-cis isomers induced both phenotypic differentiation and G1/0 specific growth arrest. The occurrence of G1/0 specific growth arrest without phenotypic differentiation indicates that the induced cellular programs leading to phenotypic differentiation and G1/0 specific growth arrest are not tightly coupled. Within the 48-h period usually required by beta-all trans RA to induce onset of phenotypic differentiation and G1/0 specific growth arrest, all isomers could complete early events in the cellular programs leading to G1/0 specific growth arrest and phenotypic differentiation, but the dicis isomers could not complete late events in the phenotypic differentiation program. The capability of dicis isomers to drive late events in the G1/0 specific growth arrest program was also compromised. Characteristic early and late changes in Ca2+ binding cytosolic proteins induced by RA and its isomers were consistent with their early and late capabilities. Failure of the dicis isomers to induce differentiation was thus due to a failure in late events associated with aberrations in cytosolic, Ca2+ binding proteins. The results suggest a model in which RA presents two signals to induce HL-60 terminal differentiation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3458975     DOI: 10.1016/0145-2126(86)90264-x

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML.

Authors:  Rodica P Bunaciu; Robert J MacDonald; Holly A Jensen; Feng Gao; Xin Wang; Lynn Johnson; Jeffrey D Varner; Andrew Yen
Journal:  Leuk Lymphoma       Date:  2018-12-20

2.  Direct effects of 13-cis and all-trans retinoic acid on normal bone marrow (BM) progenitors: comparative study on BM mononuclear cells and on isolated CD34+ BM cells.

Authors:  D R van Bockstaele; M Lenjou; H W Snoeck; F Lardon; P Stryckmans; M E Peetermans
Journal:  Ann Hematol       Date:  1993-02       Impact factor: 3.673

3.  Induction of differentiation of human promyelocytic leukemia cell line HL-60 by retinoyl glucuronide, a biologically active metabolite of vitamin A.

Authors:  M H Zile; M E Cullum; R U Simpson; A B Barua; D A Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  Retinoic acid induced differentiation and commitment in HL-60 cells.

Authors:  P A Meyer; C Kleinschnitz
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.